Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers

Clinical trial NCT03761914 · COMPLETED

Trial details

NCT number: NCT03761914
Sponsor: Sellas Life Sciences Group
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myelogenous Leukemia Ovarian Cancer Colorectal Cancer Triple-negative Breast Cancer Small-cell Lung Cancer

Start date: 2019-09-30
Primary completion: 2022-07-05
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.